Drug Profile
Renal failure therapy - RenaMed Biologics
Alternative Names: Renal Bio-Replacement TherapyLatest Information Update: 29 Jun 2015
Price :
$50
*
At a glance
- Originator RenaMed Biologics
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Renal failure